Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

Abroad (travel likely)Recruiting

Conditions

Metastatic Colorectal Cancer · BRAF V600E Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Ralph Fritsch, MD

    Study Chair

    University of Zurich